EDSA — Edesa Biotech Share News
0.000.00%
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Edesa Biotech drops on $25 mln stock-and-warrants offering
Edesa Biotech tumbles on planned equity offering
Edesa Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Edesa Biotech Q3 loss widens on higher R&D costs
Edesa Biotech Inc expected to post a loss of 58 cents a share - Earnings Preview
Edesa Biotech Inc expected to post a loss of 58 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
Edesa Biotech Q2 net loss widens as R&D spending rises
NASDAQ RESUMED AT 10:11 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:01 AM
NASDAQ RESUMED AT 09:45 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
Brief: Edesa Biotech Reports Additional Results From Phase 3 Paridiprubart Study
Canada's Edesa Biotech Q1 net loss widens
Skin drug developer Edesa Biotech's FY net loss widens to $7.2 mln
Brief: Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study